<http://www.wikidata.org/entity/statement/Q63816609-3D9D476B-E52D-4F5C-AD2B-A91F8A26DEBD>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Statement> .
<http://www.wikidata.org/entity/statement/Q63816609-3D9D476B-E52D-4F5C-AD2B-A91F8A26DEBD>	<http://wikiba.se/ontology#rank>	<http://wikiba.se/ontology#NormalRank> .
<http://www.wikidata.org/entity/statement/Q63816609-3D9D476B-E52D-4F5C-AD2B-A91F8A26DEBD>	<http://www.wikidata.org/prop/statement/P1476>	"A Phase II Evaluation of ABT-888 (NCI Supplied Agent: ABT-888, NSC #737664), Topotecan (NSC # 609699) and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Squamous or Non-squamous Cell Carcinoma of the Cervix"@en .
<http://www.wikidata.org/entity/statement/Q63816609-3D9D476B-E52D-4F5C-AD2B-A91F8A26DEBD>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#BestRank> .